Time to achieve a prostate-specific antigen nadir of ≤0.2 ng/mL and related factors after permanent prostate brachytherapy
Author:
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Oncology
Reference31 articles.
1. The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma;Blasko;Radiother Oncol,2000
2. 10-Year biochemical (prostate-specific antigen) control of prostate cancer with 125I brachytherapy;Grimm;Int J Radiat Oncol Biol Phys,2001
3. Combined modality treatment in the management of high-risk prostate cancer;Stock;Int J Radiat Oncol Biol Phys,2004
4. Interpreting a rising prostate-specific antigen after brachytherapy for prostate cancer;Gaztañaga;Int J Urol,2013
5. Prostate-specific antigen bounce after permanent iodine-125 prostate brachytherapy — an Australian analysis;Zwahlen;Int J Radiat Oncol Biol Phys,2011
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Impacto de la realización de resonancia magnética multiparamétrica (RMmp) antes de la braquiterapia en pacientes con cáncer de próstata;Actas Urológicas Españolas;2023-10
2. Prior MRI-imaging impact of patients submitted to brachytherapy for prostate cancer;Actas Urológicas Españolas (English Edition);2023-10
3. Definitions of “Cure” After Low-Dose-Rate Brachytherapy in Low- and Intermediate-Risk Prostate Cancer: Phoenix or Surgical?;Advances in Radiation Oncology;2023-03
4. How long is long enough to secure disease control after low-dose-rate brachytherapy in combination with other modalities in intermediate-risk, localized prostate cancer?;International Journal of Clinical Oncology;2021-10-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3